Papanek Julie Grant, Director at Day One Biopharmaceuticals, Inc. (DAWN), sold 2,600 shares at $20.00 ($52K) on 2022-07-18, disclosed to the SEC on 2022-07-20.
Open-market sale of $52k DAWN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DAWN | SELL | 2022-08-08 | $200K | — | Filing → |
| DAWN | SELL | 2022-07-12 | $25K | — | Filing → |
| DAWN | SELL | 2022-07-12 | $36K | — | Filing → |